Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedixTSE:331A 20 Buyback Yield % is 5.99 as of Aug. 01, 2026, which is 1% below its 10-year median of 6.08. GuruFocus rates TSE:331A with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 320 Media - Diversified companies, Medix ranks better than 90.62% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
The historical data trend for Medix's Buyback Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:331A vs APP, OMC, TTD: Buyback Yield % Comparison
For the Advertising Agencies subindustry, Medix's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medix Buyback Yield % vs Media - Diversified Industry
For the Media - Diversified industry and Communication Services sector, Medix's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Medix's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medix (TSE:331A) has a Buyback Yield % of 5.99 as of Aug. 01, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medix and its competitors. This is near median its historical median of 6.08. According to the industry distribution chart, Medix ranks #30 out of 320 companies in the Media - Diversified industry, placing it in the top 9.4%.
Is Medix's Buyback Yield % too high?
Medix's current Buyback Yield % of 5.99 is near median its 10-year median of 6.08. Based on the distribution chart, Medix ranks #30 out of 320 companies in the Media - Diversified industry, which is in the top quartile — a strong position relative to peers. Overall, Medix has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Medix's Buyback Yield % compare to APP and OMC?
According to the Media - Diversified industry distribution chart, Medix ranks #30 out of 320 companies for Buyback Yield %. This places Medix in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Media - Diversified company?
A good Buyback Yield % depends on the Media - Diversified industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Medix and its competitors. Medix's current Buyback Yield % is 5.99, which is near median its own 10-year median of 6.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medix stock overvalued right now?
Medix (TSE:331A) has a current Buyback Yield % of 5.99. The current Buyback Yield % is 5.99, which is near median its 10-year median of 6.08. Medix's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Medix (TSE:331A), the current Buyback Yield % is 5.99 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Medix Inc is an internet advertising agency that places the utmost importance on understanding its clients' business models deeply and helping them solve problems over the medium to long term. It is engaged in Digital marketing services including creative design and production, data parsing and analysis, and Internet advertising services. The company provides services in the digital marketing field to clients in various lines and industries.
20GF Score
Get the complete analysis for TSE:331A
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:331A has been successfully added to your 
